Cargando…

Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

OBJECTIVE: The purpose of this study was to evaluate the effect of bisphosphonates in improving bone mineral density (BMD) and decreasing the occurrence rate of fractures and adverse events in patients with inflammatory bowel disease (IBD). METHODS: Randomized controlled trials (RCTs) which use bisp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yan, Chen, Xiaoting, Chen, Xiaojing, Zhang, Shuang, Jiang, Tianyan, Chang, Jing, Gao, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585544/ https://www.ncbi.nlm.nih.gov/pubmed/28913325 http://dx.doi.org/10.1155/2017/2736547

Ejemplares similares

Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis
por: Yao, Liwei, et al.
Publicado: (2017)

Bisphosphonates for Prevention of Bone Loss in Glucocorticoid-Treated Young People
por: Reid, Ian R.
Publicado: (2019)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis
por: Shi, Jialing, et al.
Publicado: (2018)

Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials
por: Yang, Yan, et al.
Publicado: (2018)

Effect of bisphosphonates in preventing femoral periprosthetic bone resorption after primary cementless total hip arthroplasty: a meta-analysis
por: Zhao, Xinyu, et al.
Publicado: (2015)

Effect of bisphosphonates on periprosthetic bone loss after total knee arthroplasty: a meta-analysis of randomized controlled trials
por: Shi, Mingmin, et al.
Publicado: (2018)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Bone Sparing Effects of Bisphosphonates in Cyclosporine-induced Alveolar Bone Loss: An Animal Study
por: Bhat, Sneha R, et al.
Publicado: (2020)

The Efficacy of Bisphosphonates in Preventing Aromatase Inhibitor Induced Bone Loss for Postmenopausal Women with Early Breast Cancer: A Systematic Review and Meta-Analysis
por: Anagha, Pooleriveetil Padikkal, et al.
Publicado: (2014)

Signaling pathways associated with bone loss in inflammatory bowel disease
por: Palatianou, Maria E., et al.
Publicado: (2023)

Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis
por: Rehman, Qaiser, et al.
Publicado: (2001)

Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss
por: Zhang, Ya-Li, et al.
Publicado: (2022)

The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
por: Byun, Ji-Hye, et al.
Publicado: (2017)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis
por: Yang, Yan, et al.
Publicado: (2018)

Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials
por: Xue, Deting, et al.
Publicado: (2014)

Bone loss in patients with the ileostomy and ileal pouch for inflammatory bowel disease
por: Gupta, Supriya, et al.
Publicado: (2013)

Effect of bisphosphonates on local recurrence of giant cell tumor of bone: a meta-analysis
por: Shi, Mingmin, et al.
Publicado: (2019)

Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Zhang, Gao, et al.
Publicado: (2021)

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
por: Guo, Jiawei, et al.
Publicado: (2023)

Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Bisphosphonate conjugation enhances the bone-specificity of NELL-1-based systemic therapy for spaceflight-induced bone loss in mice
por: Ha, Pin, et al.
Publicado: (2023)

Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
por: Rajput, Swati, et al.
Publicado: (2023)

Periodontitis and inflammatory bowel disease: a meta-analysis
por: She, Yang-yang, et al.
Publicado: (2020)

A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation
por: Coffman, Abigail A, et al.
Publicado: (2021)

The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis
por: Gao, Yongquan, et al.
Publicado: (2021)

Bisphosphonates for the Prevention and Treatment of Osteoporosis in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis
por: Feng, Zhiyun, et al.
Publicado: (2013)

Prevention of bisphosphonate-related mandibular fractures
por: Pedrazzoli, M., et al.
Publicado: (2016)

2325: Steroid therapy limits stem cell activation required to enact mucosal healing in inflammatory bowel disease
por: Brady Lynch, Evan, et al.
Publicado: (2018)

Bisphosphonates Versus Denosumab for Prevention of Pathological Fracture in Advanced Cancers With Bone Metastasis: A Meta-analysis of Randomized Controlled Trials
por: Al Farii, Humaid, et al.
Publicado: (2020)

Reply to: A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation
por: Coffman, Abigail A, et al.
Publicado: (2021)

Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysis
por: Peng, Jing, et al.
Publicado: (2016)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Bisphosphonate conjugation for bone specific drug targeting
por: Farrell, Kristen B., et al.
Publicado: (2018)

Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease
por: Yin, Yi, et al.
Publicado: (2022)

Annual alveolar bone loss in older adults taking oral bisphosphonate: a retrospective cohort study
por: Helmi, Mohammad, et al.
Publicado: (2019)

Effects of Bisphosphonate on Osteocyte Proliferation and Bone Formation in Patients with Diabetic Osteoporosis
por: Weng, Beifang, et al.
Publicado: (2022)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
por: Lee, Emily Sunny, et al.
Publicado: (2023)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_qm5ialg650fnttjt918oi5rqtd